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Abstract

SYNTHESIS AND CHARACTERIZATION OF A NOVEL AMPHIPHILIC CORE-CORONA
HYPERBRANCHED POLYMER, COMPOSED OF EHMO AND EHMOPEG, FOR DRUG
DELIVERY
By Khushboo Sharma, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Biomedical Engineering at Virginia Commonwealth University.

Virginia Commonwealth University, 2010

Research Director: Dr. Hu Yang
Assistant Professor, Biomedical Engineering

A

novel

amphiphilic

core-corona

hyperbranched

polymer,

composed

of 3-ethyl-3-

(hydroxylmethyl) oxetane (EHMO) and PEGylated EHMO (EHMOPEG), was synthesized
through cationic ring opening polymerization. Nuclear Magnetic Resonance spectroscopy
(NMR), Dynamic Light Scattering (DLS), and Fourier Transform Infrared spectroscopy (FTIR)
were used to characterize the polymer structure and degree of branching. It was found that the
degree of branching (DOB) of the polymer was affected by the weight % ratios of
EHMO/EHMOPEG used in polymerization. As the weight % ratio of EHMO/ EHMOPEG
decreased, the DOB was observed to increase. Polymeric particles based on the synthesized
polymer were prepared using the O/W (Oil in Water) solvent emulsion method and evaluated for
ix

drug delivery. Scanning Electron Microscopy (SEM) and Dynamic Light Scattering (DLS) were
used to characterize the size and shape of the particles. The obtained particles were found to be
spherical in shape and have a narrow size distribution. Camptothecin (CPT) was used as the
model drug for drug encapsulation and controlled release studies. The loading and encapsulation
efficiencies of the particles ranged between 60% and 80%. Cytotoxicity studies carried out with
human skin fibroblasts indicated that as the weight % ratio of the EHMO/ EHMOPEG decreased
the biocompatibility of the polymer increased. In vitro drug release studies showed that the CPT
could be released over an extended period of time. The efficacy of the drug released from the
particles was demonstrated by the MTT assay on HN12 cells. The results showed that the
cellular activity decreased as the amount of drug released from the particles increased over a
span of 72 hours. The synthesized polymer represents a new family of hyperbranched
macromolecule with potential for drug delivery.

x

CHAPTER 1 INTRODUCTION

For a long time, pharmaceutical formulations mostly comprised quick acting and
simple substances that could be easily administered either orally or injected directly.1
However, over the last few decades, the scenario has been changing and the need for
formulations with controlled release and specificity has increased significantly.1 Various
efforts are being centered on not only the synthesis of better vehicles to carry drug
formulations but also their administration routes. The encapsulation of drugs into a
delivery vehicle for site specific delivery has become an important strategy to reduce
degradation of drugs, which otherwise reduces and limits their efficacy before they reach a
specified site for action.2 Additionally, these vehicles are designed to overcome various
problems such as drug toxicity, burst release, etc.1, 2 A number of drug delivery systems
have been developed for drug delivery, including liposomes, microspheres, and
nanoparticles.3, 4 Polymeric drug delivery systems are attractive vehicles for drug delivery
as they can serve as a means of effectively controlling drug dose and for targeting specific
regions in the body.1 The use of polymeric drug delivery systems for example poly(lactic
acid) based delivery system, dated back to early 1970s.1 Most polymers being investigated
for drug-delivery applications are either linear (non-branched) or cross-linked in nature.5-7
Recent developments in polymers with hyper branched and defined architectures have
opened new opportunities for developing more efficient drug delivery systems.

1

This thesis work involves synthesis and characterization of a novel amphiphilic core
corona hyperbranched polymeric system. This polymeric system was explored as a carrier
for delivery of hydrophobic drugs. Cationic ring opening polymerization was used for the
synthesis using 3-ethyl-3-(hydroxymethy) oxetane (EHMO) and PEGylated EHMO
(EHMOPEG) as monomers. Four different polymers were prepared by varying the molar
ratios of EHMO/ EHMOPEG for this study. Techniques such as Fourier Transform Infrared
spectroscopy, Scanning Electron Microscopy, Dynamic Light Scattering, Differential
Scanning Calorimetry and Nuclear Magnetic Resonance spectroscopy were used to
characterize the synthesized monomer and polymers. This hyperbranched polymer was
further formulated into particles using single oil-in-water (O/W) emulsion/solvent method
and evaluated for delivery of anticancer drug camptothecin.

2

CHAPTER 2 BACKGROUND

2.1 A brief history of branched polymers
Vogtle was the first to introduce the idea of hyperbranched polymer.8 This study led to the
concept of insistent growth, which was applied to the synthesis of low molecular weight
amines.8 Before this discovery, there were only three major polymer classes based on
polymer architecture – linear, crosslinked and branched.5-8 After the iterative reaction
scheme was identified, many researchers have developed interests in exploring synthesis
and applications of such hyperbranched structures. Macromolecular architectures of
branched polymers can be divided into three major classes: dendrimers3, dendrigrafts3, and
hyperbranched polymers.5 Since then a number of hyperbranched polymers including
dendrimers have been developed, such as poly(propylene imine) (PPI) dendrimers by
Wörner/ Mülhaupt9 and Brabender-van den Berg/Meijer10, poly(amidoamine) (PAMAM)
dendrimers by Tomalia et al.11, 12 and dendri-poly(ethers) along with dendripoly(thioethers)
by Newkome et al.13, 14

2.2 Dendrimers
Dendrimers are the best characterized subclass. They possess unique properties such as
mono-dispersity and highly symmetrical structure. Their basic architectural components
include a core, interior units comprising of various branches and surface functional
groups.7, 8, 15 Dendrimers are formed by repetitive sequence of reaction steps, where with
3

each successive step molecular weight and generation number become higher than the
previous7. Two common ways applied for dendrimer synthesis are convergent and
divergent methods. The divergent method as shown in Figure 1,15, 16 involves the addition
of monomer and then the subsequent building up of the structure from the core eventually
proceeding outwards to the periphery of the molecule.7,

8, 15

The symmetric branched

structure is formed by covalently attaching a new generation to the reactive sites present in
the core.7,

15

In this method the number of reactions increase exponentially for each

subsequent generation.7, 15 Reaction at each step of synthesis must be completed in order to
avoid any trailing generation that might form if some branches are shorter than the others.
These impurities might impair the functionality and symmetry of the dendrimer.7, 15
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Figure 1: Divergent method of dendrimer synthesis.

The convergent method as shown in Figure 2,

15, 16

uses small terminal moieties or groups

attached to a monomer with masked functional groups for initiating the process.7, 15 In this
method, the reaction and growth proceed from outside to inward towards the core.7, 15 This
method has advantages including easy removal of impurities to help sustain the
functionality of dendrimer, and reduction of the number of transformations required to
connect every consecutive generation.7,

15

However, sterical hindrances cause crowding

and hence the generation of dendrimers formed by this method is not very high.7, 15

5

Figure 2: Convergent method of dendrimer synthesis.

Some examples of the polymers prepared by the divergent method are poly(amidoamine)
(PAMAM)11, 12 and poly(propylene imine) (PPI) dendrimers11, 12 and those prepared by the
convergent method are poly(benzyl ether) dendrimers.11, 12 Their molecular weights can be
controlled as required.7,

17

The number of their surface functional groups increases

exponentially while their diameter increases linearly with increase in generation.5 Their
surface functional groups play a significant role in determining material properties and can
be modified to get a desired property.5, 18 Dendrimers, have lower viscosities and higher
solubility than their linear analogues.5, 19

2.3 Dendrigraft polymers
Another subset of hyperbranched polymers are dendrigraft polymers,20, 21 which are known
as semi-controlled polymers as their structures are not as well defined as dendrimers.3
Similar to dendrimers, dendrigraft polymers consist of a core, interior with branches and
various terminal functional groups. However, unlike dendrimers, their grafting sites are
6

distributed quite randomly.3 They can be prepared by divergent ‘grafting onto’ method as
shown in Figure 3.21 Some examples of successfully synthesized dendrigrafts are poly (2ethyl-2-oxazoline) (PEOX) oligomers grafted onto linear poly(ethylene imine) substrates.20

functionalization

linear
Generation 0
functionalization

Generation 1

Figure 3: Synthesis of dendrigraft polymer.

2.4 Hyperbranched polymers
Hyperbranched polymers have received considerable attention in recent years due to their
versatile architecture and many potential applications.3,

22

They have been exploited as

drug delivery vehicles because their architecture can be aptly modulated to obtain desired
properties. For instance, functional groups on the surface can be engineered to influence
their properties such as glass transition temperature, solubility, mechanical properties, and
melt viscosity.22,

23

Hyperbranched polymers are poly-disperse but less complicated to
7

synthesize when compared to dendrimers.22, 24, 25 Their cost-effective manufacturing makes
them attractive for large scale applications. One of the most attractive features of
hyperbranched polymers is the absence of entanglement and low viscosity in bulk and
solution.5

Different methods including self poly-condensation polymerization, proton

transfer polymerization, and ring opening chain polymerization have been exploited for the
synthesis of hyperbranched polymers.22, 24

2.4.1 Methods for synthesis of hyperbranched polymers
There are two major methods used for the polymerization of hyperbranched polymers:
single monomer methods (SMM),26 where only monomer ABx is required for
polymerization; and double monomer methods (DMM),26 where the polymerization
requires two different types of monomers.

2.4.1.1 Polycondensation of ABx monomers
Self poly-condensation is a one step reaction, which is useful for polymerization of ABx
monomers.27-29 Examples of polymers prepared by this method are polyethers,27-29
polyesters,30 and polycarbonates.31 The reaction is shown in the following scheme (Figure
4).22

8

Figure 4: Self poly-condensation of AB2 monomer

Requirements for self poly-condensation vinyl polymerization (SCVP) are a double bond
and an initiation moiety in the monomer. The reaction takes place in the following manner
(Figure 5).22

Figure 5: Self poly-condensation vinyl polymerization

2.4.1.2 Proton-transfer polymerization (PTP)
PTP is dependent on the basicity and acidity of monomers as shown in Figure 6.32 This
concept has been used for synthesis of various hyperbranched polymers such as an
aliphatic hyperbranched polyether derived from a diepoxide and a trifunctional alcohol
group.33, 34

9

Figure 6: Proton transfer polymerization.

2.4.1.3 Ring-opening polymerization (ROP)
The third method is the ring opening polymerization which was earlier known as multibranching polymerization since the number of chain terminals increases with progression
of polymerization.7,

24

Molecular weight distribution of the polymers generated by this

method can be controlled by moderating the addition of proper initiators to generate
various numbers of active sites.7, 24 One of the examples of ring opening polymerization is
shown in Figure 7.22
10

Figure 7: Ring opening polymerization.

2.4.2 Degree of Branching
For maximizing the advantages of hyperbranched polymer, it is important to understand
their structure-property relationship.6, 35 Degree of branching is one of the most important
aspects of this relationship. Hyperbranched polymers consist of dendritic unit (D), linear
unit (L), and terminal unit (T) as shown in Figure 8,22 which influence the degree of
branching of the polymer.6, 35

11

Figure 8: Degree of branching.

Degree of branching can be calculated by the following equation.6, 23

Values for dendritic units, linear units, and terminal units can be determined by integrating
the corresponding peaks in

13

C NMR. Degree of branching has a huge impact on

hyperbranched polymer’s physical and chemical properties. Recently it was reported that
the degree of branching could be controlled by many factors including monomer to catalyst
ratio, and temperature. It has been proposed that the degree of branching increases with
temperature.36

12

2.4.3 Properties of hyperbranched polymers
Glass transition temperature governs the thermal behavior of hyperbranched polymers.37
Factors such as chain end groups, molar mass and macromolecular composition influence
the glass transition temperature of a given polymer.37 Increase in the degree of branching
results in a change of the glass transition temperature, which can be explained using free
volume concept.38 Particularly, polymers with more branches occupy more free space.
Therefore, the restriction in the movement of the chains can only be overcome at higher
temperature.5,

22, 24

Due to less entanglements and more organized branched structure,

hyperbranched polymers have different mechanical properties from crosslinked polymers5,
22, 24

Because of their globular structure, chain extension and orientation become difficult,

hence resulting in strain hardening. Melt viscosity of hyperbranched polymers is much
lower than that of their linear polymers.20, 21 Intrinsic viscosity (as described by the MarkHouwink equation) and hydrodynamic volumes are lower for hyperbranched polymers
than for their linear analogues due to differences in their structural arrangement. 5

2.5 Drug delivery
Drug delivery systems can help improve the specificity, bio-distribution and efficacy of
drugs.1, 2 Since polymers have a capacity of being customized, they are good substitutes to
replace the earlier established carriers such as viruses, and protein conjugates which have
limitations such as poor stability and non-specificity.1, 2 Several commonly used methods
for drug delivery based on polymers are polymer-drug conjugate,1,

2

drug encapsulating

polymeric micelles,1, 2 and multicomponent polyplexes.1, 2 Encapsulation of a drug in the
13

polymeric micelles is realized by trapping the drug in the internal core through
hydrophobic-hydrophobic interactions. Polymer-drug conjugates, on the other hand, are
usually prepared by covalently coupling drug to polymer.1, 5 Polymeric nanoparticles have
shown great promise as drug carriers in the biomedical field.4, 39 Nanoparticles can be one
of two types: firstly monolithic nanocapsules1, 2,

39

in which drug is encapsulated in the

hydrophobic or hydrophilic core surrounded by a shell; and secondly nanospheres1,
which can encapsulate the drug through out the entire matrix.1,

2

2, 39

They help overcome

hurdles that are usually faced with direct administration of drugs. They increase the
solubility and action specificity of drugs.2,23,39 They are small in size and easy to
administer and result in high cellular uptake. 2, 39 The most important property they possess
is their ability to release the entrapped drug in a well controlled manner.1, 23 Amphiphilic
polymers play an important role in the delivery of hydrophobic drugs. 23, 39 They arrange
themselves in a manner where the hydrophobic drug can be encapsulated in the polymer’s
hydrophobic. Meanwhile, a hydrophilic PEG layer offers stealth properties to the vehicle
and help extend its half life.1, 2, 23

3-ethy-3-(hydroxymethyl) oxetane was selected as the monomer 1 for polymerization as it
is a trifunctional monomer which can be reacted to form a hyperbranched structure.
Monomer 2 was synthesized by attaching a PEG chain to monomer 1 to provide
biocompatibility to the monomer, which could further be imbibed in the polymer.

14

CHAPTER 3 MATERIALS AND METHODS

3.1 Materials
Table 1: List of materials used
Material

Abbreviation

3-ethyl 3-(hydroxymethyl) oxetane
(monomer 1)
Boron trifluoride diethyl etherate
Dichloromethane
Chloroform
Methanol
De-ionized water
Triethyl anhydride
4-nitro phenyl chloroformate
Tetrahydrofuran
Dimethylformamide
Dimethyl Sulfoxide
Hexane

EHMO

DCM

DI water
TEA
NPC
THF
DMF
DMSO

15

3.2 Equipment
Table 2: List of equipments and machines used:
Equipment name
Nuclear Magnetic Resonance
(NMR)

Use
400 MHz spectrometer was used to
carry out proton and carbon13
measurements

Dynamic Light Scattering
(DLS)

To measure the hydrodynamic radius
of nanoparticles and also to measure
molecular weight of the polymers

Flexi-dry MP controlled rate freezer
(FTS systems, Inc.)
Differential Scanning Calorimetry
(DSC)
Scanning Electron Microscopy
Model EVO 550
UV-Vis spectrophotometer

To freeze dry the samples

To determine the glass transition
temperature of the polymers
To take photographs of the nanoparticles
To conduct quantitative analysis for
drug release studies
Eppendorf Centrifuge Model- F-45-24- To centrifuge samples to separate
11
liquid phase from suspended phase
Fourier Transform Infrared
For characterization of the polymer
spectroscopy (FT-IR)

16

3.3 Synthesis
3.3.1 Monomer synthesis
PEGylated EHMO (i.e., monomer 2) was synthesized by substituting the hydroxyl group
present on 3-ethyl 3-(hydroxymethyl) oxetane with NH2-PEG-OCH3 (MW= 2000 daltons
and 550 daltons) group as described in a previously reported method.23

Method of preparation of monomer 2:
As shown in Scheme 1, monomer 1 (0.29 g) was weighed and dissolved in 5 ml of THF.
To this solution, 0.252 g (347 µl) and 0.500 g NPC were added. The mixture was stirred
for 24 hours and then centrifuged at 5000 rpm for 20 minutes to remove the salt. The
supernatant was collected and rotovaporated to remove the solvent. The obtained dry
product was further reacted with NH2-PEG-OCH3 (0.335 gm) in 5 ml of DMF at room
temperature. After 72 hours, dialysis was performed for the purification of the final
product using a 500 molecular weight cut off membrane (500 MWCO). The sample
obtained after dialysis was freeze dried to get dry monomer 2 (EHMOPEG) with a yield of
60%.

Calculation:
Weight of the intermediate product obtained = 281 g/ mole
Amount of intermediate product being used = 0.05 g which is equivalent to 1.77*10 -4
moles
Molecular weight of NH2-PEG-OCH3 being used = 2000 g/ mole

17

Since we want to keep the molar ratio as 1:1 therefore amount of PEG to be used = 0.335
g (1.77*10-4 moles)

Scheme 1: PEGylated monomer synthesis

3.3.2 Synthesis of polymer
Cationic ring opening polymerization40,

41

was used for synthesis of hyperbranched

polymer as shown in Scheme 2. The reaction was carried out in a three necked round
bottom flask using a PTFE stirrer for mixing. The glassware used was washed well and
dried in oven for few hours. The whole reaction set up was first degassed and dried
completely by passing nitrogen from it for 30 minutes. The flask was placed on a heating
mantle with temperature maintained at 100°C for first half an hour and then at 45°C for
rest of the reaction. At 30 minutes, the nitrogen source was removed and the solvent,
18

dichloromethane (15 ml) and the catalyst BF3O(C2H5)2 were added to the flask. Within
five minutes the monomer 1 was introduced and the flask temperature was maintained
constant at 45°C. After the reaction was allowed for 48 hours, monomer 2 was added in to
the flask and the reaction proceeded for another 24 hours. At the end of 72 hours the
reaction was quenched by ethanol. The resultant polymer was dried in the vacuum oven at
60°C for two days. Four different poly(EHMO-EHMOPEG) co-polymers with various
monomer 1: monomer 2 ratios (i.e.98.2:1.8 wt%, 96:4 wt%, 74.4:25.6 wt%, 17:83 wt%)
were prepared. The first three polymers were prepared using EHMO modified with PEG
chain of 2000 daltons and the last polymer with ratio 17:83 wt% (EHMO/EHMOPEG) was
prepared using the monomer with a shorter PEG chain (MW= 550 daltons). This was done
in order to reduce the steric hindrance in the polymerization and also to determine its
influence on properties of the polymers. The yields of the obtained polymers ranged
between 50-66% being highest for 98.2:1.8 and lowest for 17:83 polymeric ratios. The
synthesized polymers are reproducible.

19

Scheme 2: Polymer synthesis

3.3.3 Preparation of polymeric particles
Single oil-in-water (O/W) emulsion/ solvent evaporation method23, 42 was used to obtain
blank and drug loaded nanoparticles. The synthesized polymers (10 mg) were dissolved in
1 ml of chloroform and 2 ml of DI water was drop wise added under magnetic stirring to
prepare the blank particles.23
Camptothecin, a hydrophobic anti cancer drug,43,

44

was used as the model drug. Drug

solution was prepared by dissolving 10 mg of drug in a mixture of chloroform: methanol
(4:1). Drug loaded nanoparticles were prepared by adding the drug solution (10 mg/ml) to
the polymer solution (10 mg/3 ml). The mixture was kept at room temperature overnight.
The equilibrated solution was then rotovaporated to remove the solvents. The particles

20

subjected to centrifugation for 1 hour at 13,200 rpm were collected and dried completely
under vacuum.

3.4 Characterization
3.4.1 Nuclear magnetic resonance spectroscopy
1

H and

13

C NMR spectra were taken to confirm the synthesis of the monomer and the

polymer on a 400 MHz Bruker NMR instrument. Chloroform-d6, DMSO- d6, D2O were
used as solvents and tetramethylsilane (TMS) was used as an internal standard. Processing
of the data obtained was performed using “spin works” (free software) software courtesy
of the University of Manitoba, Canada. The chemical shifts for the respective solvents are
as follows:
Table 3: NMR shifts for commonly used solvents
NMR spectroscopy solvent

Chemical shift (ppm)

Carbon shifts

D2O

Proton shifts

DMSO- d6
Chloroform- d6
D2O
DMSO- d6
Chloroform- d6

40.4
77.3
4.8
2.5
7.2

Degree of branching was also calculated using 13C-NMR. The triplet peaks obtained at 43
ppm were integrated to obtain the values. Integration of the first peak, second peak and the
third peak provided the values for the dendritic(D) units, Linear(L) unit, and the
terminal(T) units as shown in Figure 8.

21

3.4.2 Differential scanning calorimetry
DSC Q-1000 (TA instrument) was used for thermal analysis by determining glass
transition temperature (Tg) and melting temperatures (Tm) of the synthesized polymers.
Samples were prepared by placing 5-6 mg of polymers in hermetic pans with lids. In the
process, the samples were first equilibrated at -40°C and then ramped up to 100°C using a
heating rate of 10°C per minute and then cycle 2 was run at a cooling rate of 10°C per
minute. The data included is after cycle 2.

3.4.3 Fourier transform infrared spectroscopy
FT-IR was also run on a Nicolet magna IR 760 spectrometer to identify and determine the
different groups present in the polymer synthesized. Plots of % transmission and
wavelength were plotted. Samples were prepared by placing 1-2 mg of polymer on the KBr
(potassium bromide) disc and drying it with a drier.

3.4.4 Dynamic light scattering
Zetasizer Nano ZS Instrument from Malvern Instruments was used to determine the size of
the particles and molecular weight of the polymer.45,

46

Dynamic light scattering is a

noninvasive method which works on the principle of light scattering and determines the
molecular weight and size of the particles by enforcing the Rayleigh equation.45, 46 Laser is
used as the light source. When the light falls on the particles, scattering of light takes place
and molecular weight is determined by the measurement of the time averaged intensity of
scattered particles. The working principle of the process is as shown in the Figure 9.47
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Laser

Focussing lens

Particle dispersion

Scattered light

Coherence optics

Correlator

Photon detector

Figure 9: Working principle of DLS

Intensity of the scattered light is proportional to the product of the weight average
molecular weight and the concentration of the solution. Debye plot between intensity of
scattered light and concentration is used for the calculation. The intercept yields the inverse
of the weight average molecular weight and toluene is used as the standard due to its high
Rayleigh ratio which helps in accurate measurement. 45, 48

Rayleigh equation:
KC/R = (1/M + 2A2C) P
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From Debye plot:
KC/R is proportional to 1/ (molecular weight in Daltons)
The size of the particles was obtained on the basis of the same principle. Samples for blank
nanoparticle size measurement studies were prepared by dissolving 1 mg of polymer in
1ml of chloroform and then adding 2 ml water under magnetic stirring at room
temperature.
3.4.5 Scanning electron microscopy
SEM was performed at the department of Anatomy and Neurobiology, (facility funded by
NIH-NINDS Center core grant 5P30NS047463 and NIH-NCRR grant 1S10RR022495) to
observe the morphology of the blank and drug loaded nanoparticles and also estimate their
diameter. Zeiss EVO-50XVP model was used with an accelerating voltage of 10kV.
Samples were prepared by putting few drops of the nanoparticle solution on a small cut
silicon wafer and drying it for 6 hours in vacuum. Each sample was gold sputter coated
(EMS 550 Automated sputter coater, Electron Microscopy Sciences) prior to its use. The
images were taken at 35000x magnification. The working principle of the scanning
electron microscopy is as shown in Figure 10.49
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Mirror
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Mirror

Detector
Figure 10: Working principle of SEM
3.5 Drug loading and encapsulation efficiency studies
Camptothecin, an anticancer hydrophobic drug, was used as a model drug43,

44

Before

conducting any drug release studies, a scanning curve for CPT (Figure 11) was taken out
using 1mg/ml solution of CPT in a mixture of chloroform and methanol (4:1) and since the
absorbance values were highest at a wavelength of 369 nm, it was used to plot the standard
curve (Figure 12) using UV-visible spectrophotometer. UV-visible spectroscopy was used
to determine the amount of CPT that was encapsulated by the nanoparticles prepared. 23
The drug loaded nanoparticles were weighed and divided in to three equal amounts. Then
all three samples were dissolved in a mixture of chloroform and methanol solvents (in the
ratio of 4:1). The samples were centrifuged for one hour at a speed of 13,200 rpm. After
one hour the absorbance values were measured at 369 nm. The drug encapsulation
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efficiency (EE) is defined as the percentage of the drug in the nanoparticle with respect to
the total amount of drug used and the loading efficiency (LE) is measured as the amount of
drug encapsulated in the nanoparticle with respect to the total amount of the nanoparticles
as shown in the following equations.23, 50

EE = (Total amount of CPT- Free amount of CPT) / Total amount of CPT
LE= (Total amount of CPT- Free amount of CPT) / Total amount of nanoparticle

3.6 Cytotoxicity studies
To evaluate the cytotoxicity of the synthesized polymeric particles, human dermal
fibroblasts (obtained from Dr. Gary L. Bowlin’s lab, Biomedical Engineering department,
VCU) cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) were used. The fibroblasts cells were incubated with blank
polymeric particles at different concentrations (0.01µg/µl, 0.05µg/µl, 0.1µg/µl, and
0.33µg/µl) at 37 °C for 48 hours. The cell viability was assessed with the MTT assay.
Another cellular assay (MTT test) was performed to determine the efficacy of the drug
loaded particles on the HN12 cells (derived from metastatic Squamous Cell Carcinoma). In
this study, poly(EHMO-EHMOPEG)50:1 with a final concentration of 0.01µg/µl was studied

3.7 Drug release study
Drug loaded polymeric particles were weighed and dissolved in 10 ml of PBS buffer in a
capped conical flask. The solution was maintained at 37 °C. At predetermined intervals
26

the entire solution was centrifuged at 3500 rpm for 15 minutes. Afterwards, 3 ml of
supernatant was collected and subjected to UV-visible measurement at 369 nm to quantify
the released drug. After each measurement, 3 ml of fresh PBS buffer was added back to
medium.23The drug release was calculated in terms of cumulative release by keeping in to
account the amount withdrawn at every measurement point. The concentration of drug at
each time point was calculated using the standard curve (Figure 12).

Calculation:
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CHAPTER 4 RESULTS AND DISCUSSION

4.1 Preparation and characterization of EHMOPEG and poly(EHMO- EHMOPEG)
NMR spectroscopy (400 MHtz) was used to confirm the synthesis of the PEGylated
monomer and the poly(EHMO- EHMOPEG). In the 1H-NMR of the monomer 1, EHMO
(Figure 13b), the peak at 4.3ppm is distinctive of the protons present in the oxetane ring of
the EHMO. 1H-NMR for the monomers (Figure 13) displayed the following peaks which
correspond to the respective groups.
Table 4: 1H-NMR shifts for monomer characterization
Chemical shift (ppm)

Group(s)

4.4

-CH2 groups of the oxetane ring

0.9

-CH3 group on the oxetane side chain

1.7

-CH2 group on the oxetane side chain

3.7

-CH2-OH

According to 1H-NMR spectrum of the polymer (Figure 14 B), disappearance of the peak
at 4.3ppm indicates the occurrence of the ring opening polymerization.
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The following other peaks were also observed:
Table 5: 1H-NMR for polymer characterization
Chemical shifts (ppm)

Group(s)

0.9

-CH3 groups

1.7

-CH2 groups

3.1

-CH2-O group

3.3

-CH2-OH

3.8

-OH group

3.5

-(CH2CH2) group

3.75

-(OCH3) group

5-8

-(NH) group

Table 6: 13C-NMR for polymer characterization
Chemical shifts (ppm)

Group(s)

9.9

-CH3 groups

21.8

-CH2 groups

43

-D+L+T groups

72

-(CH2CH2) groups

62

-CH2OH group
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Figure 13: 1H-NMR spectra of monomers
a) EHMOPEG
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Figure 14: NMR spectra of different polymeric ratios
A) 13C-NMR spectrum of poly(EHMO-EHMOPEG2000)98.2:1.8
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B) 1H-NMR spectrum of poly(EHMO-EHMOPEG2000)98.2:1.8

a
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b
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C) 13C-NMR spectrum of poly(EHMO-EHMOPEG2000)96:4

c

b

c

a

f

e
d

D) 1H-NMR spectrum of poly(EHMO-EHMOPEG2000)96:4

c

a
b
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E) 13C-NMR spectrum of poly(EHMO-EHMOPEG2000)74.4:25.6

c

c
a
e

b

f
d

F) 1H-NMR spectrum of poly(EHMO-EHMOPEG2000)74.4:25.6

c
a
b
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G) 13C-NMR spectrum of poly(EHMO-EHMOPEG550)17:83
c

e`

c
f
d

b

a

H) 1H-NMR spectrum of poly(EHMO-EHMOPEG550)17:83
c

b
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4.2 Degree of branching
The major attraction of the polymer synthesized is its hyperbranched characteristic. We
can calculate its degree of branching using the following equation:
DOB = (D+T)/ (D+L+T)
D, L, T represent the dendritic (D), linear (L) and the terminal (T) units of the
hyperbranched polymer (as described earlier in Figure 8). The DOB is calculated by the
integration of the peaks for the D, L and T units found around 43ppm in the carbon-13
NMR (Figure 15 A,B,C and D). Degree of branching obtained for various ratios is shown
in Table 7. The results indicate that the degree of branching increases with increase in
monomer 2 which contributes mostly to the branches of the polymer.

Table 7: Degree of branching of various polymeric ratios
Polymer

Degree of Branching

Poly(EHMO-EHMOPEG2000)98.2:1.8

17.9 %

Poly(EHMO-EHMOPEG2000)96:4

48.47%

Poly(EHMO-EHMOPEG2000)74.4:25.6

76.4%

Poly(EHMO-EHMOPEG550)17:83

78%
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Figure 15: NMR spectra of Degree of branching
A) poly(EHMO-EHMOPEG2000)98.2:1.8

B) poly(EHMO-EHMOPEG2000)96:4

C) poly(EHMO-EHMOPEG2000)74.4:25.6
37

D) poly(EHMO-EHMOPEG550)17:83

4.3 Mechanisms governing the reactions
38

The synthesis of the hyperbranched polymer is governed by two mechanisms known as
Active Chain End mechanism (ACE) and Activated Monomer Mechanism (AMM).
Polymerization is initiated by protonation of the oxygen atom in the oxetane ring which is
attacked (nucleophilic) by the free hydroxyl group present on monomer 1 (EHMO). Active
monomer mechanism leads to the formations of the branched core structure whereas the
active chain mechanism contributes to the formation of the linear hydrophilic branches as
shown in Scheme 3 below.

Scheme 3: Mechanism of polymer synthesis
A) Initiation

B) Propagation via AMM mechanism
39
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C) ACE mechanism
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D) Termination

4.4 Fourier transform infrared spectroscopy
From the data obtained for FT-IR, we observed strong transmittance peaks at 2880 cm-1 for
alkane groups, and at 1110.4 cm-1 for ether groups. A stretching peak at 1740 cm-1 was
also observed for C=O bond. The results obtained from FT-IR confirm that the polymer
synthesis.
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Figure 16: FT-IR plots for different polymeric ratios
A) Poly(EHMO-EHMOPEG2000)98.2:1.8
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C) Poly(EHMO-EHMOPEG2000)74.4:25.6
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4.5 Differential scanning calorimeter
Thermal transitions were studied using differential scanning calorimetry. Glass transition
temperatures were recorded as shown in Table 8. The glass transition temperature
decreased with increase in the degree of branching. Glass transition temperature is
influenced by free volume available for the motion of the chains and free chain ends.38
PEG chains have a low Tg at -32 °C due to which the values for Tg keeps on decreasing as
the amount of monomer 2 which has a PEG chain attached to it increases.

Table 8: Glass transition temperatures
Polymer

Glass transition temperature

Poly(EHMO-EHMOPEG2000)98.2:1.8 (a)

-31.5 °C

Poly(EHMO-EHMOPEG2000)96:4 (b)

-53.5 °C

Poly(EHMO-EHMOPEG2000)74.4:25.6 (c)

-43.5 °C

Poly(EHMO-EHMOPEG550)17:83 (d)

-55.5 °C
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Figure 17: DSC curves
A) poly(EHMO-EHMOPEG2000)98.2:1.8

Temperature (°C)
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B) poly(EHMO-EHMOPEG2000) 96:4

47

C) poly(EHMO-EHMO PEG2000)74.5:25.6

48

D) poly(EHMO-EHMOPEG550)17:83
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E) Combined curve for all the polymers
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4.6 Molecular weight

Dynamic light scattering (DLS) was also used to determine the molecular weight of the
polymers using toluene as the standard. The weights determined from DLS were as shown
in Table 9. The results show that the molecular weight keeps increasing as the degree of
branching and amount of monomer 2 increases.

Table 9: Molecular weight determined from DLS
Polymer

Molecular weight

Poly(EHMO-EHMOPEG2000)98.2:1.8

20.96 kDa

Poly(EHMO-EHMOPEG2000)96:4

28.1 kDa

Poly(EHMO-EHMOPEG2000)74.4:25.6

34.34 kDa

Poly(EHMO-EHMOPEG550)17:83

7.8 kDa

4.7 Preparation of polymeric particles
Both blank and drug loaded nanoparticles were prepared by the method described earlier
and their morphology and size were characterized using SEM (scanning electron
microscopy) and DLS (dynamic light scattering). SEM images (Figure 18) shows that the
particles were mostly circular in shape and the diameter ranged from 200 nm to 500 nm
depending upon the copolymer composition. The spherical shape of the particles was
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maintained after the drug was encapsulated. DLS was also used to provide quantitative size
information. The size of polymeric particles obtained from DLS ranged between 250 nm
and 700 nm and were found to be consistent with the SEM results. The difference in size
measured by both techniques was possibly due to the method by which the samples were
prepared for SEM. Since the samples were obtained by putting a few drops of the solution
on silicon wafers and then drying them in the vacuum oven for 4-6 hours, there is a
possibility that the drying might have caused the shrinkage of the particles.23, 25 The size of
the drug loaded particles was bigger than that of the blank particles indicating the
encapsulation of the drug into the particles as shown in the Figure 19.

Table 10: Particle size determined using DLS and SEM
Blank particle sizes

DLS (nm)

SEM (nm)

Poly(EHMO-

685.5 ± 5.25

450-550

509 ± 5.50

480-450

361 ± 7.20

150-200

1078 ± 5.60

900-1000

EHMOPEG2000)98.2:1.8
Poly(EHMOEHMOPEG2000)96:4
Poly(EHMOEHMOPEG2000)74.4:25.6
Poly(EHMOEHMOPEG550)17:83
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The particle size was found to be decreasing with increase in the amount of monomer 2
which mostly form the hydrophilic branches of the polymer. This behavior is in
accordance to the Eisenberg et al. theory 42 which says that thermodynamics of aggregation
governs the size of the micelles. They proposed three sources which may influence the
behavior of micelles namely, the core, core-solvent interaction, and shell-solvent
interaction.
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Figure 18: SEM images of blank polymeric particles
A) Poly(EHMO-EHMOPEG2000)98.2:1.8

B) Poly(EHMO-EHMOPEG2000)96:4
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C) Poly(EHMO-EHMOPEG2000)74.4:25.6

D) Poly(EHMO-EHMOPEG550)17:83
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Figure 19: Comparison study between blank and drug loaded particles:
A) Poly(EHMO-EHMOPEG2000)98.2:1.8
Before drug encapsulation

After drug encapsulation
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B) Poly(EHMO-EHMOPEG2000)96:4
Before drug encapsulation

After drug encapsulation
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C) Poly(EHMO-EHMOPEG2000)74.4:25.6
Before drug encapsulation

After drug encapsulation
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D) Poly(EHMO-EHMOPEG550)17:83
Before drug encapsulation

After drug encapsulation
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4.8 Cytotoxicity studies
Cytotoxicity tests were performed using human dermal fibroblasts cells. Positive control
was used, where the fibroblast cells were incubated with zero concentration of polymer.
The studies clearly indicated that addition of PEG to the polymer reduced the cytotoxicity
of the material. Cell viability was the highest for the polymer with the maximum amount
of PEG i.e. poly(EHMO-EHMOPEG550)17:83 as shown in Figure 20. Cell images (Figure 21)
confirm that the cells incubated were not affected in terms of morphology. As seen in both
cell viability assay and cell imaging analysis poly(EHMO-EHMOPEG550)17.83 was the least
toxic. Figure 21 further shows the effect of increasing concentrations (from 0.01 µg/µl to
0.33 µg/µl) of different polymeric ratios on the fibroblast cells. The cytotoxicity studies
suggest the cytotoxicity of the polymeric particles is dose and composition dependent.

Figure 20: Cytotoxicity studies
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poly(EHMO-EHMOpeg2000)96:4

100
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Figure 21: Microscopic images for cytotoxicity studies
A) Poly(EHMO-EHMOPEG2000)98.2:1.8
i) 0.01µg/µl

ii) 0.05µg/µl
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iii) 0.1µg/µl

iv) 0.33µg/µl
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B) Poly(EHMO-EHMOPEG2000)96:4
i) 0.01µg/µl

ii) 0.05µg/µl

63

iii) 0.1µg/µl

iv) 0.33µg/µl

64

C) Poly(EHMO-EHMOPEG2000)74.4:25.6
i) 0.01µg/µl

ii) 0.05µg/µl

65

iii) 0.1µg/µl

iv) 0.33µg/µl

66

D) Poly(EHMO-EHMOPEG550)17:83
i) 0.01µg/µl

ii) 0.05µg/µl

67

iii) 0.1µg/µl

iv) 0.33µg/µl
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CHAPTER 5 DRUG RELEASE KINETICS

5.1 Loading and encapsulation studies
Camptothecin (CPT), an anticancer hydrophobic drug was used as the model drug.
Loading and encapsulation efficiencies were calculated for the different polymeric ratios
and the results were as shown. The DOB increase caused to decrease the size of the core of
the particles which, in turn led to the decrease in loading capacity.23

Table 11: Loading efficiencies
Polymer

Loading efficiencies in %

Poly(EHMO-EHMOPEG2000)98.2:1.8

80

Poly(EHMO-EHMOPEG2000)96:4

73.8

Poly(EHMO-EHMOPEG2000)74.4:25.6

65

Poly(EHMO-EHMOPEG550)17:83

66

69

Table 12: Incorporation Efficiencies
Polymer

Incorporation Efficiency in %

Poly(EHMO-EHMOPEG2000)98.2:1.8

66

Poly(EHMO-EHMOPEG2000)96:4

65

Poly(EHMO-EHMOPEG2000)74.4:25.6

64

Poly(EHMO-EHMOPEG550)17:83

60

5.2 Drug release study
The drug release kinetics as shown in Figure 22, indicates that all poly(EHMO-EHMOPEG)
polymeric particles display a similar release pattern. A small burst effect takes place in the
beginning between 1 to 20 hours and then a controlled and sustained release is observed.
The order of release kinetics ranges from 0.3 to 0.7. The burst effect as observed in the
beginning can be attributed to rapid diffusion of the drug that did not get trapped in the
core. Therefore, the drug in the outer shell or on the surface released faster whereas, the
core encapsulated drug releases at a much sustained manner. Since the drug used is a
hydrophobic drug, hydrophobic interactions are the main reason for the controlled drug
release. The release of the drug is also related to the degree of branching of the synthesized
polymers. As indicated Figure 22, the release rate decreases with the increase in degree of
branching. As the DOB increases, it causes more obstruction in the release of the drug and
also causes the size of the particles to decrease as explained above. As a consequence the
release rate also decreases. The release of the drug is mostly governed by diffusion of
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water across the branched polymer. However, steric hindrance was also observed to have
an influence over the drug release rate. The polymer with PEG550 (Poly(EHMOEHMOPEG)17:83) was found to have a higher release rate than the polymer with PEG2000
(Poly(EHMO-EHMOPEG)74.4:25.6). This indicates that the drug release was slowed down by
the presence of lengthier PEG chains.
Figure 22: Drug release kinetics
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5.3 Cellular assay
Cellular assay was performed on HN12 cells to determine the efficacy of the encapsulated
drug.

MTT

test

conducted

with

0.5µg/µl

of

concentration

of poly(EHMO-

EHMOPEG2000)74.4:25.6 showed that as the time increased from 12 to 72 hours the amount of
cellular activity reduced indicating the release of drug from the particles as shown in
Figure 23. The release was controlled and took place slowly over a period of time as
indicated by the drug release studies. The percentage of the cellular activity became as low
as 10% after 72 hours which indicated high potency of the drug.

Figure 23: Cellular assay
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5.4 Conclusions
A new family of amphiphilic core-corona hyperbranched polymer, composed of EHMO
and PEGylated EHMO was synthesized through cationic ring opening polymerization. It
was characterized with NMR, FT-IR, DLS and DSC. Oil in water emulsion method was
applied to formulate the synthesized polymers into particles for drug delivery.
Degree of branching was found to be dependent on the weight % ratio of
EHMO/EHMOPEG and has a significant impact on polymeric properties including glass
transition temperature, and drug loading efficiency. CPT can be released at a controlled
and sustained rate. Addition of PEG chains to the polymer reduced the toxicity of the
resulting hyperbranched polymer and made them more biocompatible.
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CHAPTER 6 SUMMARY AND FUTURE WORK

Hyperbranched polymers have unique physical and chemical properties due to
which they find potential applications in various fields including drug delivery to
coatings.26 They possess highly branched and three dimensional dendritic architecture,
which makes them highly adaptable. We synthesized a novel amphiphilic polymeric
system with potential for drug delivery and controlled release. We demonstrated the effect
of addition of the monomer 2 (monomer with PEG chains) on the thermal properties,
mechanical properties and drug release kinetics. We used Camptothecin, an anticancer
hydrophobic drug for drug release studies; various other hydrophobic drugs can be used for
future studies. All the studies done here were in vitro, therefore future studies must be done
in vivo to get a better insight into how to utilize the synthesized polymeric system in
human. Thermal analysis was done in this study to determine glass transition temperatures
and its influence on the material. Further studies can be done to determine if the polymeric
system shows any thermoresponsiveness.
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